Torrent Pharmaceuticals Ltd. - Research Center
500420 TORNTPHARM Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
4,267.00 |
3,861.00 |
3,248.00 |
3,494.00 |
3,367.00 |
Operating profit |
1,473.00 |
1,285.00 |
905.00 |
1,195.00 |
1,196.00 |
Interest |
167.00 |
113.00 |
106.00 |
130.00 |
183.00 |
Gross profit |
1,332.00 |
1,212.00 |
899.00 |
1,169.00 |
1,029.00 |
EPS (Rs) |
19.20 |
17.70 |
23.10 |
35.45 |
34.33 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
26.00 |
40.00 |
100.00 |
104.00 |
16.00 |
Stock adjustment |
-86.00 |
98.00 |
-18.00 |
- |
-66.00 |
Raw material |
867.00 |
740.00 |
757.00 |
772.00 |
716.00 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
735.00 |
615.00 |
535.00 |
563.00 |
562.00 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
1,278.00 |
1,123.00 |
1,069.00 |
964.00 |
959.00 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
375.00 |
305.00 |
299.00 |
303.00 |
303.00 |
Taxation |
307.00 |
308.00 |
209.00 |
266.00 |
145.00 |
Net profit / loss |
650.00 |
599.00 |
391.00 |
600.00 |
581.00 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
169.23 |
169.23 |
84.62 |
84.62 |
84.62 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
34.52 |
33.28 |
27.86 |
34.20 |
35.52 |
GPM (%) |
31.03 |
31.07 |
26.85 |
32.49 |
30.42 |
NPM (%) |
15.14 |
15.36 |
11.68 |
16.68 |
17.17 |